Compare Acadia Healthcare Company Inc (ACHC) vs S&P Global Inc (SPGI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Acadia Healthcare Company Inc vs S&P Global Inc — how do they compare? Acadia Healthcare Company Inc trades at $31.73 (market cap $2.99B), while S&P Global Inc trades at $424.38 (market cap $130.19B). The key difference: S&P Global Inc is far larger — about 43.5× Acadia Healthcare Company Inc's market cap, and S&P Global Inc pays a 0.88% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.
| ACHC | SPGI | |
|---|---|---|
Market Cap | $2.99B | $130.19B |
Sector | Health | Financials |
52-Week High | $35.61 | $534.79 |
52-Week Low | $11.68 | $370.42 |
Enterprise Value | $5.50B | $142.16B |
Dividend Yield | — | 0.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ACHC trades at $32.50, down 5.82% over 24 hours, with a bullish technical signal from moving averages and a consensus analyst price target of $33.63. The company has beaten earnings estimates for the last three quarters, including a recent Q2 2026 beat of $0.38 per share versus $0.33 expected (Zacks Investment Research, 2026-07-28). However, it reported a net loss of $1.10 billion for 2025, reflecting significant profitability challenges despite revenue growth.
The outlook is mixed, with strong analyst buy ratings (68%) and operational improvements supporting upside potential, but substantial net losses and ongoing securities litigation pose material risks to shareholder value. The stock's investment case hinges on successful execution of its turnaround strategy amid margin pressures.
S&P Global (SPGI) trades at $424.36, down 0.48% on the day, with strong fundamentals including 30.36% net income margin and consistent earnings beats in three of the last four quarters. The stock shows bullish technical momentum with moving averages supporting upward trends, while analyst consensus remains overwhelmingly positive with 85.7% buy ratings and a $532.10 price target representing 25% upside potential.
The outlook remains favorable given robust revenue growth to $15.3B in 2025, strategic acquisitions expanding market presence, and strong cash flow generation. Key risks include elevated valuation multiples and increasing debt levels, but the company's dominant market position and strategic initiatives support continued growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Acadia Healthcare Company Inc
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →About S&P Global Inc
S&P Global provides data and benchmarks to capital and commodity market participants. In 2021 and excluding IHS Markit, S&P Ratings was over 45% of the firm's revenue and over 55% of the firm's operating income. S&P Ratings is the largest credit rating agency in the world. The firm's other segments include Market Intelligence, Indices, and Platts. Market Intelligence provides desktop tools and other data solutions to investment banks, corporations, and other entities. Indices provides benchmarks for financial markets and is monetized through subscriptions, asset-based fees, and transaction-based royalties. Platts provides benchmarks to commodity markets, principally petroleum.
Read more on SPGI →
